CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Polsky Bruce Director | Grant or award · Restricted Stock Units | +26,700 | 26,700 | ||
| 2026-06-18 | Polsky Bruce Director | Grant or award · Stock Option (Right to Buy) | +37,700 | 37,700 | ||
| 2026-06-18 | Murphy Polly A. Director | Option exercise | +29,600 | 121,745 | ||
| 2026-06-18 | Murphy Polly A. Director | Option exercise · Restricted Stock Units | −29,600 | 0 | ||
| 2026-06-18 | Murphy Polly A. Director | Grant or award · Restricted Stock Units | +26,700 | 26,700 | ||
| 2026-06-18 | Murphy Polly A. Director | Grant or award · Stock Option (Right to Buy) | +37,700 | 37,700 | ||
| 2026-06-18 | KIRSCH ARTHUR S Director | Grant or award · Restricted Stock Units | +26,700 | 26,700 | ||
| 2026-06-18 | KIRSCH ARTHUR S Director | Grant or award · Stock Option (Right to Buy) | +37,700 | 37,700 | ||
| 2026-05-18 | Murphy Polly A. Director | Purchase | +6,100 | $4.17 | $25K | 92,145 |
| 2026-03-11 | Corcoran Andrea See Remarks | Option exercise | +60,000 | $1.24 | $74K | 823,576 |
| 2026-03-11 | Corcoran Andrea See Remarks | Option exercise · Stock Option (Right to Buy) | +60,000 | 0 | ||
| 2026-02-03 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise | +300,000 | $1.24 | $372K | 767,830 |
| 2026-02-03 | Sommadossi Jean-Pierre President, CEO, and Chairman | Option exercise · Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2026-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise | +51,283 | 112,159 | ||
| 2026-01-31 | Horga Maria Arantxa Chief Medical Officer | Shares withheld for taxes | −16,073 | $4.24 | $68K | 96,086 |
| 2026-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise · Restricted Stock Units | −41,533 | 0 | ||
| 2026-01-31 | Horga Maria Arantxa Chief Medical Officer | Option exercise · Restricted Stock Units | −9,750 | 0 | ||
| 2026-01-31 | Horga Maria Arantxa Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +173,500 | 173,500 | ||
| 2026-01-31 | Vavricka John Chief Commercial Officer | Option exercise | +42,083 | 94,164 | ||
| 2026-01-31 | Vavricka John Chief Commercial Officer | Shares withheld for taxes | −11,570 | $4.24 | $49K | 82,594 |
Page 2 of 14 · 280 trades